{"id":"W2145434047","doi":"10.1016/s1470-2045(14)70417-6","title":"Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; McMaster University","funders":"Janssen Research and Development; National Cancer Institute","keywords":"Abiraterone acetate; Prostate cancer; Medicine; Oncology; Chemotherapy; Protocol (science); Internal medicine; Castration; Abiraterone; Cancer; Urology; Androgen deprivation therapy; Alternative medicine; Hormone; Pathology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000626966,0.000204931,0.0009600341,0.0001292589,0.0001222138,0.0001064051,0.0003094692,0.00005324063,0.0001000634],"category_scores_gemma":[0.00004381229,0.0001061626,0.00006377717,0.0004993433,0.0002483634,0.0001846759,0.00008353697,0.0001477591,0.00000138357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001849558,"about_ca_system_score_gemma":0.0004372459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002408679,"about_ca_topic_score_gemma":0.0006947275,"domain_scores_codex":[0.9982018,0.0002692697,0.0004162622,0.0003432101,0.0003027747,0.0004666804],"domain_scores_gemma":[0.998576,0.0001758018,0.0004019491,0.0003638719,0.0003902427,0.00009208291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.867996,0.003049622,0.07971589,0.0006192496,0.003794356,0.00001638371,0.001763176,0.00005410783,0.0007259047,0.00002200214,0.000253573,0.04198973],"study_design_scores_gemma":[0.697377,0.02325371,0.256343,0.0003623879,0.004404973,0.000001732437,0.00007794447,0.002744985,0.002145966,0.0001184422,0.01283046,0.0003394175],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9111521,0.00003893242,0.00009277635,0.002207463,0.00004959637,0.08618813,0.0001419911,0.00001847581,0.0001105178],"genre_scores_gemma":[0.7926154,0.0000185491,0.00440272,0.0003845294,0.0001530284,0.2017717,0.0001051603,0.0000371255,0.0005117581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1766271,"threshold_uncertainty_score":0.4329185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1270490815713082,"score_gpt":0.4639079775581205,"score_spread":0.3368588959868123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}